CalciMedica, Inc.
(NASDAQ: CALC)
CalciMedica, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate, Auxora, helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.
4.370
-0.200
(-4.38%)
Range
4.260 - 4.570
(7.28%)
Open
4.570
Previous Close
4.570
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
61,216
Value
-
Remark
Delayed prices. Updated at 06 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
